Korro Bio Inc (KRRO)

Jun 02, 2026

Korro Bio CEO Ram Aiyar sells $196,672 in company stock - Investing.com

Jun 02, 2026

Jun 02, 2026

Korro Bio CEO Ram Aiyar sells $196,672 in company stock By Investing.com - Investing.com UK

Jun 02, 2026

Jun 01, 2026

Korro Bio director sells $39,897 in common stock By Investing.com - Investing.com Australia

Jun 01, 2026

Jun 01, 2026

Korro Bio director sells $39,897 in common stock - Investing.com

Jun 01, 2026

May 29, 2026

Korro Bio Inc. (KRRO) Faces Selling Pressure as Shares Retreat 3.21%Bear Pennant - The Legal Advocate

May 29, 2026

May 29, 2026

KRRO Q1 2026 Earnings: EPS Beat by 10.05% as Biotech Advances PipelineNext Quarter Guidance - The Legal Advocate

May 29, 2026

May 29, 2026

Press Release: Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors - Moomoo

May 29, 2026

May 28, 2026

Piper Sandler Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $30 - Moomoo

May 28, 2026

May 28, 2026

Korro Bio, Inc. (KRRO) Reports Q3 Loss, Lags Revenue Estimates - MSN

May 28, 2026

May 27, 2026

Korro Bio, Inc. identifies surge in healthcare burden from ammonia in hepatic encephalopathy - Traders Union

May 27, 2026

May 27, 2026

Korro Bio (KRRO) Receives a Buy from H.C. Wainwright - The Globe and Mail

May 27, 2026

May 27, 2026

Korro to Present at the 2026 Jefferies Global Healthcare Conference - The Manila Times

May 27, 2026

May 26, 2026

H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 26, 2026

May 23, 2026

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come - Bez Kabli

May 23, 2026

May 21, 2026

Korro Bio Inc. (KRRO) Surges Nearly 12% as Biotech Momentum BuildsExpert Momentum Signals - Newser

May 21, 2026

May 21, 2026

Citigroup initiates coverage of Korro Bio (KRRO) with buy recommendation - MSN

May 21, 2026

May 20, 2026

Korro Bio Selects KRRO-111 as RNA Editing Therapy Candidate for Alpha-1 Antitrypsin Deficiency (AATD) with Best-in-Class Preclinical Results 1 - Minichart

May 20, 2026

May 19, 2026

Korro Bio, Inc.Common Stock (NQ: KRRO - The Chronicle-Journal

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact By Investing.com - Investing.com South Africa

May 19, 2026

May 19, 2026

Korro Bio nominates new candidate for AATD - BioWorld News

May 19, 2026

May 19, 2026

H.C. Wainwright Maintains Korro Bio(KRRO.US) With Buy Rating, Cuts Target Price to $15 - Moomoo

May 19, 2026

May 19, 2026

Korro Bio, Inc. selects KRRO-111 after preclinical success in repairing AAT protein - Traders Union

May 19, 2026

May 19, 2026

H.C. Wainwright cuts Korro Bio stock price target on financing impact - Investing.com Nigeria

May 19, 2026

May 19, 2026

Korro Bio Advances KRRO-111 for Alpha-1 Deficiency - TipRanks

May 19, 2026

May 19, 2026

Korro Bio adds AATD treatment candidate to pipeline - Investing.com

May 19, 2026

May 18, 2026

KRRO Initiates Coverage by Citigroup -- Announces Buy Rating - GuruFocus

May 18, 2026

May 18, 2026

Citi Initiates Korro Bio(KRRO.US) With Buy Rating, Announces Target Price $21 - Moomoo

May 18, 2026

May 18, 2026

Lynx1 Capital Management LP's Korro Bio Inc(KRRO) Holding History - GuruFocus

May 18, 2026

May 18, 2026

Citigroup Initiates Korro Bio at Buy With $21 Price Target - marketscreener.com

May 18, 2026

May 16, 2026

Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

May 16, 2026

May 15, 2026

Should You Sell Korro Bio (KRRO) After -8.12% Drop? 2026-05-15Stock Picks - Newser

May 15, 2026

May 15, 2026

Korro Bio, Inc. advances KRRO-121 RNA editing therapy for hyperammonemia toward clinical stage - Traders Union

May 15, 2026

May 15, 2026

New Korro Bio hire gets option for 3,000 shares at $11.20 - Stock Titan

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 13, 2026

Korro Bio (KRRO) Price Target Decreased by 30.76% to 66.30 - MSN

May 13, 2026

May 11, 2026

Korro announces oversubscribed $85 million private placement - MSN

May 11, 2026

May 10, 2026

Number of shareholders of Korro Bio, Inc. – NASDAQ:KRRO - TradingView

May 10, 2026

May 09, 2026

Korro Bio (NASDAQ:KRRO) Announces Quarterly Earnings Results - MarketBeat

May 09, 2026

May 08, 2026

Wave Life Sciences (WVE) Attracts Positive Attention Amid Compet - GuruFocus

May 08, 2026

May 08, 2026

JonesTrading Upgrades Korro Bio(KRRO.US) to Buy Rating, Announces Target Price $23 - Moomoo

May 08, 2026

May 08, 2026

Jones Trading upgrades Korro Bio stock rating on AATD program potential By Investing.com - Investing.com South Africa

May 08, 2026

May 08, 2026

Jones Trading upgrades Korro Bio stock rating on AATD program potential - Investing.com Nigeria

May 08, 2026

May 08, 2026

Chardan Capital Maintains Korro Bio(KRRO.US) With Buy Rating, Maintains Target Price $15 - Moomoo

May 08, 2026

May 07, 2026

Korro Bio Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2026

May 07, 2026

Korro Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026